BEVITAL AS

Transportation

Before shipment of samples several factors have to be considered to achieve optimal sample conditions, and to avoid sample thawing or loss during transportation.

Secure Logistics for Stable Samples.

1. Aliqoting and sample mixing

When sample for transportation and analysis is taken from a source vial, great care must be taken to ensure proper mixing of the content before pipetting. During freezing and thawing, gradients of serum/plasma components, in particular of albumin, are formed. Simple vortexing, in particular if the vial is full, may not be sufficient to generate a homogeneous solution. Therefore, repeated tilting of the vial with a small air bubble is recommended. Avoid foaming. Pipetting from vials that have solute gradients will affect analyte concentration to a variable extent. Albumin-bound biomarkers, like total homocysteine and total cysteine, are most seriously affected (up to 20 % difference).

2. Packing and organization

The samples must be placed in sufficient dry ice to keep them frozen for 4 – 5 days. Thus, a box with 6 – 800 samples should contain about 10 kg of dry ice. The samples should be placed in 1-2 mL vials with a screw cap, and clearly labelled with serial numbers, printed (not hand-written) on a label, which tolerates freezing. They must be placed and immobilized in boxes accommodating 100 vials, and sorted in a sequence which matches an accompanying excel data sheet with serial number and additional unequivocal identification. This excel file must be send to us by e-mail the day the parcel is dispatched.

3. Sample sequence

The samples are analyzed in the order provided on the excel sheet and according to the organization of the vials in the boxes used for transportation. If you have special requirements for the sequence of the analyses (paired cases and controls, randomization, longitudinal sampling, etc…), you have to organize your samples accordingly. Please contact us if you have questions concerning sample sequence organization.

4. Courier

The parcel must be marked with VALUE = 10 (USD or EURO), to avoid custom delay and extra cost.

Samples should be transported by a competent courier on dry ice:
– For US and other overseas shipments we recommend WORLD COURIER, which allows dry ice and guarantees refilling of dry ice if required. The company has local representatives in Norway, takes care of all paperwork and thereby avoids that the parcel is stuck in the customs office. WORLD COURIER is expensive, e.g. transportation of 1 item of 10 kg to/from USA costs about 1500€; 3 items about 2000 €.
– We have also used QUICK International for overseas shipment.
– For shipment within Europe we have used DHL, which after agreement allows dry ice, but does not refill ice; it is quick and not expensive. The company has local representative in Bergen. FedEx should be avoided, since this company does not transport with dry ice within Norway, and the shipment stops in Oslo.

The parcel should preferably be dispatched on a Monday, to avoid over weekend delay. At the day of transportation please notify Randi Mjelde Heimdal (randi.heimdal@bevital.no) or post@bevital.no about the day of shipment and AIR WAY BILL NUMBER. It is also recommended that you track your shipment during transportation, and notify us if samples are delayed.

Please sent the samples to:
Randi Mjelde Heimdal
Bevital AS
Frydenbøgården 5. etg.
Minde Allé 35
5068 Bergen, Norway

March 17, 2026
Scroll to Top

Per Christian Eriksen

Øivind

Per Magne Ueland has been Professor at the University of Bergen 1987-2018. He is one of the founders of Bevital AS and the scientific advisor in Bevital since 2023. His interests includes biomarkers related to nutrition, inflammation, ageing and life-style related chronic diseases. Per is committed to the development of precise, high-throughput mass spectrometry methods, tailored for metabolic profiling of biobank specimens from large cohorts.

Ove completed his education in Biomedical Science at the Western Norway University of Applied Sciences, supplemented by specialized training in Electrical Engineering and Electronics at the Royal Norwegian Naval Training Establishment and the National Institute of Technology. With many years of experience as a biomedical scientist in hospital laboratories—specializing primarily in microbiology—he brings a unique blend of clinical and technical expertise to his work. Ove focuses on the design and prototyping of electronics, as well as the service and maintenance of laboratory instrumentation, ensuring that technical equipment and workflows remain precise and reliable for research-focused activities.

Lena holds a master’s degree in biology from the University of Bergen, where her thesis focused on identifying whale skeletons using zooarchaeology by mass spectrometry (ZooMS). At Bevital, she works with LC‑MS/MS analyses and method development, focusing on accurate and reliable testing of biological samples. She is dedicated to ensuring precise and high‑quality results that contribute to reliable scientific outcomes and support ongoing research efforts.

Marit holds a degree in chemical engineering from Bergen Ingeniørhøyskole, which is now part of the Western Norway University of Applied Sciences. She works with quantitative analysis and method development on LC-MS/MS at the laboratory of Bevital AS.

Randi holds a Master of Science in Chemical Process Engineering from the Norwegian University of Science and Technology (NTNU). She has been part of Bevital since its very beginning, contributing her expertise primarily to the LC-MS/MS platforms, but also to the microbiological assays. In 2021, she stepped into the role of Manager/CEO, where she is dedicated to strengthening Bevital’s innovative profile and ensuring the company’s continued growth and success. She is especially motivated by advancing research that improves health insights and by fostering collaboration that drives scientific and technological progress.

Ove completed a bachelor’s degree in Biomedical Laboratory Sciences at the Western Norway University of Applied Sciences in Bergen. With extensive experience in method development and expertise in GC-MS/MS, he specializes in optimizing analytical techniques for research-focused studies. At Bevital, Ove is dedicated to advancing laboratory methods and workflows, contributing to innovative research through precise and reliable analytical solutions.

Lene holds a bachelor’s degree in Biomedical Laboratory Science from the Western Norway University of Applied Sciences, where she is also completing her master’s degree in Medical Laboratory Technology, expected to graduate in 2026. Her master’s thesis focuses on method validation in fatty acid analysis. At Bevital, she works with GC-MS/MS analyses, routinely performing SCFA measurements and emphasizing accurate and reliable testing of biological samples. With her strong laboratory background, Lene is committed to delivering high-quality results that support medical research.

Klaus earned his PhD in physics from the University of Münster in Germany. For more than thirty years he has specialized in Time‑of‑Flight mass spectrometry, contributing innovative approaches to SNP genotyping and protein quantification. Together with his colleague Lene Njåstad, he oversees Bevital’s Olink Proteomics service. He also leads Bevital’s website and media design efforts, ensuring a clear and informative public presence.

Adrian holds a PhD in diabetes research, along with bachelor’s and master’s degrees in biomedical science and public health, respectively. With over 20 years of experience in laboratory science, he leads high-precision metabolite analyses and method development at Bevital. His expertise centers on quantifying biomarkers, metabolite classes, and metabolic pathways related to nutrition, cardiovascular and neurodegenerative diseases, and cancer. Adrian is committed to advancing research quality and actively collaborates nationally and internationally, leveraging targeted metabolomics to support innovative, multidisciplinary research.

Statistical power is the probability that a statistical test will correctly reject a false null hypothesis (H0​) when a specific alternative hypothesis (H1​) is true. H0​ is the null hypothesis, which states there is no effect or no difference. H1​ is the alternative hypothesis, which states there is a real effect or difference. Alpha (α) is the probability of a Type I error (a false positive), which is the risk of incorrectly rejecting the H0​ when it is actually true. You set this value before the experiment, commonly at 0.05. Beta (β) is the probability of a Type II error (a false negative), which is the risk of failing to reject the H0​ when it is actually false.

Power is calculated as 1−β. Increasing power means you are decreasing the probability of making a Type II error.

Several factors can be adjusted to increase the power of a statistical test:

  • Effect Size: This is the magnitude of the difference you are trying to detect. A larger effect size is easier to detect, thus increasing power. 

  • Sample Size: The number of observations in a study. A larger sample size provides more information about the population, reducing the margin of error and increasing the power to detect a true effect.

  • Variation: Refers to the spread or standard deviation of the data within the population. Less variation makes it easier to distinguish a real effect from random noise, thereby increasing power.

  • Alpha (): Increasing the alpha level (e.g., from 0.05 to 0.10) also increases power, but at the cost of a higher risk of a Type I error. This trade-off is often undesirable.

579 entries « 28 of 29 »
541.

Holm, PÃ¥l I; Ueland, Per Magne; Kvalheim, Gry; Lien, Ernst A

Determination of choline, betaine, and dimethylglycine in plasma by a high-throughput method based on normal-phase chromatography-tandem mass spectrometry Journal Article

In: Clin Chem, vol. 49, no. 2, pp. 286–294, 2003, ISSN: 0009-9147.

Abstract | Links | BibTeX

542.

El-Khairy, Lina; Vollset, Stein E; Refsum, Helga; Ueland, Per M

Plasma total cysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study Journal Article

In: Am J Clin Nutr, vol. 77, no. 2, pp. 467–472, 2003, ISSN: 0002-9165.

Abstract | Links | BibTeX

543.

Meleady, Raymond; Ueland, Per M; Blom, Henk; Whitehead, Alexander S; Refsum, Helga; Daly, Leslie E; Vollset, Stein Emil; Donohue, Cait; Giesendorf, Belinda; Graham, Ian M; Ulvik, Arve; Zhang, Ying; and, Anne-Lise Bjorke Monsen

Thermolabile methylenetetrahydrofolate reductase, homocysteine, and cardiovascular disease risk: the European Concerted Action Project Journal Article

In: Am J Clin Nutr, vol. 77, no. 1, pp. 63–70, 2003, ISSN: 0002-9165.

Abstract | Links | BibTeX

544.

Bjelland, Ingvar; Ueland, Per M; Vollset, Stein Emil

Folate and depression Miscellaneous

2003, ISSN: 0033-3190.

Links | BibTeX

545.

Schneede, J; Ueland, P M; Kjaerstad, S I

Routine determination of serum methylmalonic acid and plasma total homocysteine in Norway Journal Article

In: Scand J Clin Lab Invest, vol. 63, no. 5, pp. 355–367, 2003, ISSN: 0036-5513.

Abstract | Links | BibTeX

546.

El-Khairy, Lina; Vollset, Stein E; Refsum, Helga; Ueland, Per M

Predictors of change in plasma total cysteine: longitudinal findings from the Hordaland homocysteine study Journal Article

In: Clin Chem, vol. 49, no. 1, pp. 113–120, 2003, ISSN: 0009-9147.

Abstract | Links | BibTeX

547.

Bor, Mustafa Vakur; Refsum, Helga; Bisp, Marianne R; Bleie, Øyvind; Schneede, Jorn; Nordrehaug, Jan Erik; Ueland, Per Magne; Nygard, Ottar Kjell; Nexø, Ebba

Plasma vitamin B6 vitamers before and after oral vitamin B6 treatment: a randomized placebo-controlled study Journal Article

In: Clin Chem, vol. 49, no. 1, pp. 155–161, 2003, ISSN: 0009-9147.

Abstract | Links | BibTeX

548.

Nexo, Ebba; Hvas, Anne-Mette; Bleie, Øyvind; Refsum, Helga; Fedosov, Sergey N; Vollset, Stein Emil; Schneede, Jorn; Nordrehaug, Jan Erik; Ueland, Per Magne; Nygard, Ottar Kjell

Holo-transcobalamin is an early marker of changes in cobalamin homeostasis. A randomized placebo-controlled study Journal Article

In: Clin Chem, vol. 48, no. 10, pp. 1768–1771, 2002, ISSN: 0009-9147.

Abstract | BibTeX

549.

Hustad, Steinar; McKinley, Michelle C; McNulty, Helene; Schneede, Jørn; Strain, J J; Scott, John M; Ueland, Per Magne

Riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in human plasma and erythrocytes at baseline and after low-dose riboflavin supplementation Journal Article

In: Clin Chem, vol. 48, no. 9, pp. 1571–1577, 2002, ISSN: 0009-9147.

Abstract | BibTeX

550.

Cappuccio, Francesco P; Bell, Rachel; Perry, Ivan J; Gilg, Julie; Ueland, Per M; Refsum, Helga; Sagnella, Giuseppe A; Jeffery, Steve; Cook, Derek G

Homocysteine levels in men and women of different ethnic and cultural background living in England Journal Article

In: Atherosclerosis, vol. 164, no. 1, pp. 95–102, 2002, ISSN: 0021-9150.

Abstract | Links | BibTeX

551.

Nurk, Eha; Tell, Grethe S; Vollset, Stein Emil; Nygård, Ottar; Refsum, Helga; Ueland, Per M

Plasma total homocysteine and hospitalizations for cardiovascular disease: the Hordaland Homocysteine Study Journal Article

In: Arch Intern Med, vol. 162, no. 12, pp. 1374–1381, 2002, ISSN: 0003-9926.

Abstract | Links | BibTeX

552.

Macko, Richard F; Kittner, Steven J; Ivey, Frederick M; Epstein, Anne; Sparks, Mary J; Hebel, J Richard; Johnson, Constance C; Wityk, Robert J; Ueland, Per M; Refsum, Helga

Effects of vitamin therapy on plasma total homocysteine, endothelial injury markers, and fibrinolysis in stroke patients Journal Article

In: J Stroke Cerebrovasc Dis, vol. 11, no. 1, pp. 1–8, 2002, ISSN: 1532-8511.

Abstract | Links | BibTeX

553.

Ren, Jicun; Ulvik, Arve; Refsum, Helga; Ueland, Per Magne

Uracil in human DNA from subjects with normal and impaired folate status as determined by high-performance liquid chromatography-tandem mass spectrometry Journal Article

In: Anal Chem, vol. 74, no. 1, pp. 295–299, 2002, ISSN: 0003-2700.

Abstract | Links | BibTeX

554.

Ulvik, A; Ueland, P M

Single nucleotide polymorphism (SNP) genotyping in unprocessed whole blood and serum by real-time PCR: application to SNPs affecting homocysteine and folate metabolism Journal Article

In: Clin Chem, vol. 47, no. 11, pp. 2050–2053, 2001, ISSN: 0009-9147.

BibTeX

555.

Ueland, P M; Monsen, A L Bjørke

Total homocysteine is making its way into pediatric laboratory diagnostics Journal Article

In: Eur J Clin Invest, vol. 31, no. 11, pp. 928–930, 2001, ISSN: 0014-2972.

Links | BibTeX

556.

Monsen, A L Bjørke; Ueland, P M; Vollset, S E; Guttormsen, A B; Markestad, T; Solheim, E; Refsum, H

Determinants of cobalamin status in newborns Journal Article

In: Pediatrics, vol. 108, no. 3, pp. 624–630, 2001, ISSN: 1098-4275.

Abstract | Links | BibTeX

557.

Nedrebø, B G; Nygård, O; Ueland, P M; Lien, E A

Plasma total homocysteine in hyper- and hypothyroid patients before and during 12 months of treatment Journal Article

In: Clin Chem, vol. 47, no. 9, pp. 1738–1741, 2001, ISSN: 0009-9147.

BibTeX

558.

Refsum, H; Yajnik, C S; Gadkari, M; Schneede, J; Vollset, S E; Orning, L; Guttormsen, A B; Joglekar, A; Sayyad, M G; Ulvik, A; Ueland, P M

Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians Journal Article

In: Am J Clin Nutr, vol. 74, no. 2, pp. 233–241, 2001, ISSN: 0002-9165.

Abstract | Links | BibTeX

559.

Vollset, S E; Refsum, H; Tverdal, A; Nygård, O; Nordrehaug, J E; Tell, G S; Ueland, P M

Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study Journal Article

In: Am J Clin Nutr, vol. 74, no. 1, pp. 130–136, 2001, ISSN: 0002-9165.

Abstract | Links | BibTeX

560.

Ulvik, A; Evensen, E T; Lien, E A; Hoff, G; Vollset, S E; Majak, B M; Ueland, P M

Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum Journal Article

In: Am J Med Genet, vol. 101, no. 3, pp. 246–254, 2001, ISSN: 0148-7299.

Abstract | Links | BibTeX

579 entries « 28 of 29 »

Olink Proteomics

Please fill out the fields below (*required).
We will respond to you ASAP.
Thank you!

Customized analyses

Please fill out the fields below (*required).
We will reply to you soon for a detailed project discussion.
Thank you for reaching out to Bevital!

Mix-and-Match

Please fill out the fields below (*required).
We will respond to you as soon as possible.

Ready-to-Run

Please fill out the fields below (*required).
We will respond ASAP.
Thank you!

Thanks for joining!

Get updates about new method developments, publications and comming events.